|
| |
Rodney P. Rocconi, M.D.
Staff Physician, Gynecologic Oncology Service
Assistant Professor of Interdisciplinary Clinical Oncology
Abraham A. Mitchell Clinical Cancer Research Scholar
Office:
USA Mitchell Cancer Institute
1660 Springhill Avenue
Mobile, AL. 36604
(251) 665-8000
rocconi@usouthal.edu
|
Professional Profile
Research Interests:
-Development of screening tests for ovarian and endometrial cancer.
Honors and Academic Achievements:
-Recipient, NIH T32 Ruth L. Kirschstein National Research Service Award, 2004
-American College of Surgeons, William Maddox Cancer Research Award, 2005
-Gynecologic Oncology Group Young Investigator Award, 2007
-National Faculty Award for Excellence in Resident Education, 2008
Education:
-M.D., University of Alabama at Birmingham. (2000)
-B.S., University of Mississippi, Oxford, MS. (1994)
Professional Appointments:
-Member, USA Mitchell Cancer Institute, 2007 – present
Service:
-Reviewer, Department of Defense, Ovarian Cancer Research Program Scientist, 2009
-Society of Gynecologic Oncologists, Executive Council Representative, 2009
-Reviewer for peer reviewed journals: Gynecologic Oncology and International Journal of Gynecologic Cancer, 2008-present
-Society of Gynecologic Oncologists Marketing and Communications, 2009-present
Scientific Focus:
Dr. Rod Rocconi’s laboratory focuses on understanding the molecular mechanisms involved in ovarian cancer progression in order to develop targeted therapies and improve treatment for patients with ovarian cancer. His work involves close collaboration with Dr. Lewis Pannell’s lab as well as Dr. Lalita Shevde-Samant’s team.
Selected Publications:
1. RP Rocconi, TM Numnum, ZB Zhu, B Lu, M Wang, M Stoff-Khalili, AA Rivera, RD Alvarez, DT Curiel, S Makhija. Icodextrin Enhances Survival in an Intraperitoneal Ovarian Cancer Murine Model Utilizing Gene Therapy. Gynecologic Oncology 2006; 103: 985-989.
2. RP Rocconi, ZB Zhu, B Lu, M Stoff-Khalili, AA Rivera, B Lu, M Wang, RD Alvarez, DT Curiel, SK Makhija. Treatment of ovarian cancer with a novel dual targeted conditionally replicative adenovirus (CRAd). Gynecologic Oncology 2007; 105: 113-121.
3. RP Rocconi, KS Matthews, MK Kemper, KE Hoskins, W Wang, MN Barnes Chemotherapy Related Myelosuppression as a Marker of Survival in Epithelial Ovarian Cancer Patients During Primary Therapy. Gynecologic Oncology 2008; 108: 336-341.
4. KS Matthews, JM Estes, MG Conner, U Manne, CK Shanmugam, JM Whitworth, WK Huh, RD Alvarez, JM Straughn, MN Barnes, RP Rocconi. Lynch Syndrome in women less than 50 years of age with endometrial cancer. Obstetrics & Gynecology 2008; 111 (5): 1161-6.
5. KS Matthews, RP Rocconi, ML Kemper, KE Hoskins, W Wang, JM Straughn The Effect of Obesity on Survival in Patients with Ovarian Cancer. Gynecologic Oncology (In Press)
|
|
|
| |
|